Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations
Authors:
- 10 May 2017
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 133 (3) , 603-607
Abstract
Drug-resistant epilepsy (DRE) occurs commonly in gliomas, possibly due to a shared mechanism of AMPA-activation involving both seizure activity and tumor growth. We tested the AMPA-receptor blocker perampanel (PER) in patients with DRE in low- and high-grade gliomas. Seizure response was defined as 50% drop in seizure frequency or as seizure-freedom. Cognitive function was examined by computerized test on cognitive speed (CTCS), which is sensitive to the type of cognitive dysfunction associated with epilepsy and use of anticonvulsants. Treatment policy included reduction of dose or discontinuation of one or more concurrent AEDs, once a seizure-free response was observed. Twelve patients were included patients, median age 41 years, 9 men versus 3 women and 6 months median duration of follow-up. An objective seizure response (75%) was observed in 9 (75%) out of 12 patients: 50%-seizure response in 3, seizure-freedom in 6, which is plainly more than seen with other types of DRE. Side-effects occurred in six patients. Cognitive function as examined by CTCS improved in six out of eight associated withlowering of concurrent AEDs. The final median dose of PER was 8 mg (varying between 2 and 12 mg). These results of an objective seizure response in 9 (75%) out of 12 patients treated by PER in DRE may be interpreted as a surrogate-marker of tumor response secondary to AMPA blockade, advancing confirmation by MR imaging. These results warrant further study of PER on tumor activity in gliomas.Keywords
This publication has 38 references indexed in Scilit:
- Predictors of seizure freedom after resection of supratentorial low-grade gliomasJournal of Neurosurgery, 2011
- Glutamate and the biology of gliomasGlia, 2010
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment?Epilepsia, 2009
- Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II TrialJournal of Clinical Oncology, 2009
- Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomasJournal of Neurosurgery, 2009
- Seizure characteristics and control following resection in 332 patients with low-grade gliomasJournal of Neurosurgery, 2008
- Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt ActivationJournal of Neuroscience, 2007
- The course of neurocognitive functioning in high-grade glioma patients1Neuro-Oncology, 2007
- Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of lifeAnnals of Neurology, 2003